menu search

Hillstream biopharma to host virtual r&d day to showcase its emerging immuno-oncology pipeline targeting drug-resistant cancers

Quatramer-based HSB-1216 combined with anti-MUC1-C antibody designed to target cancer stem cells (CSCs) by inducing ferroptosis in drug resistant canc...

February 6, 2023, 12:00 pm

3 stocks that are better candidates for stock splits in 2023 than amazon was last year

There's no guarantee these stocks will split this year. But their share prices are certainly high enough to do so....

February 5, 2023, 5:50 am

Cathie wood is still a bitcoin evangelist but she’s getting candid about what she got wrong: ‘we tempered a few assumptions’

Cathie Wood is finally admitting she got some things wrong about Bitcoin. The founder and CEO of ARK Investment Management said Thursday that she and ...

February 4, 2023, 11:14 pm

Nvidia and 5 other stocks at high risk for short selling

22V Research put together a list of candidates, and said many are likely to see reversals in February....

February 3, 2023, 3:25 pm

Companies have shifted from hiring at all costs to retention, says recruiter.com ceo evan sohn

Evan Sohn, CEO of Recruiter.com, joins 'The Exchange' to discuss the labor landscape, candidate prefere...

February 2, 2023, 2:06 pm

Option trade can make money on lithium stock while it forms its base

Lithium stock Albemarle is working on a possible handle to its cup base and is a short iron condor candid...

February 1, 2023, 2:14 pm

Morphosys: negative enterprise value biotech, but lack of near-term catalyst

MorphoSys AG is a German commercial-stage biopharmaceutical company founded in 1992 with more than 100+ pipeline ...

February 1, 2023, 9:21 am

Haleon's reported strategic m&a dismissed as 'highly unlikely' and unwanted headache

Haleon PLC's (LSE:HLN, NYSE:HLN) reported interest in large 'strategic scale' acquisitions, such as with Sanofi's consumer arm, have been panned by ...

February 1, 2023, 8:50 am

Why is transcode therapeutics (rnaz) stock up 45% today?

TransCode Therapeutics (NASDAQ: RNAZ ) stock is rocketing higher on Wednesday following positive study results. The big news here has to do with TTX-R...

February 1, 2023, 8:03 am

Live oak bank’s voice of the customer survey offers in-depth analysis of customer sentiment

WILMINGTON, N.C., Jan. 31, 2023 (GLOBE NEWSWIRE) — Live Oak Bank has released its first Voice of the Customer survey, powered by Barlow Research Ass...

January 31, 2023, 9:35 pm

Moderna (mrna) rsv jab for older adults gets fda breakthrough tag

Moderna (MRNA) announces that the FDA granted Breakthrough Therapy Designation to its respiratory syncytial virus (RSV) vaccine ...

January 31, 2023, 9:30 am

Japan finance minister suzuki says too early to decide if the boj agreement needs revision

Japan finance minister Suzuki says its too early to judge whether the joint Government - Bank of Japan statement needs to be revised.

-

...

January 30, 2023, 11:48 pm

Bluesphere bio appoints erkut bahceci, m.d., as chief medical officer

Dr. Bahceci brings more than two decades of combined clinical and drug development experience PITTSBURGH, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) — Blue...

January 30, 2023, 3:17 pm

Briacell therapeutics: fast-tracking high-potential breast cancer immunotherapy

BriaCell Therapeutics aims to create cancer immunotherapy by irradiating and engineering existing cancer cells. Lead ...

January 30, 2023, 8:02 am

Boj leadership group contender says monetary policy must be revamped

USD/JPY taking a hit.

Japan think tank head Okina, considered among candidates to join new BO...

January 30, 2023, 4:25 am

Could this vaccine become sanofi's latest blockbuster?

This vaccine candidate could be approved in newborns and infants later this year....

January 29, 2023, 8:45 am

Robert half sees permanent- and temp-job placement revenue drop-off in january

Robert Half International Inc.'s stock rallied Friday after fourth-quarter profit beat expectations, but the staffing-services company provided a mixe...

January 27, 2023, 2:01 pm

Activist elliott to nominate directors at salesforce -sources

Elliott Management Corp, the activist investment firm that recently made a multimillion-dollar investment in Salesforce , plans to nominate several di...

January 26, 2023, 6:06 pm

Travere therapeutics: upcoming 'pdufa' date for kidney disease therapy is critical

Travere Therapeutics, Inc. is set to find out on Feb 17th whether the FDA has granted accelerated approval to lead drug ...

January 26, 2023, 12:05 pm

Pliant therapeutics (plrx) surges 44% in a week: here's why

Shares of Pliant Therapeutics (PLRX) have been rising since management reported positive interim data from a mid-stage study evaluating a higher dose ...

January 25, 2023, 12:02 pm


Search within

Pages Search Results: